Indivior Pharmaceuticals Inc (INDV) Investment Research Dashboard
About Indivior Pharmaceuticals Inc (INDV) stock analysis
Get live INDV stock price $40.29, comprehensive Indivior Pharmaceuticals Inc stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time INDV stock data and investment insights.
Loading chart data...
Indivior Pharmaceuticals Inc (INDV) Overview
Indivior Pharmaceuticals Inc (INDV) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, INDV trades at $40.29 with a market capitalization of 5.03B . Over the past 52 weeks, INDV has traded between $16.99 and $42.81 , with the current price positioned at approximately 90% of this ra...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
- Market cap: 5.03B
- Current price: $40.29
- 52-week range: $16.99 - $42.81
- P/E ratio: 13.39
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmace...
Company Information
- CEO
- Joseph J. Ciaffoni
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 838
Contact Information
- Website
- https://www.indivior.com
- Address
- 10710 Midlothian Turnpike
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 13.4)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Indivior Pharmaceuticals Inc shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Indivior Pharmaceuticals Inc
- ⚠Investors should consider how Indivior Pharmaceuticals Inc fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
5.03B
P/E Ratio (TTM)
13.39
Beta
1.15
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare INDV with peer companies:
- Price
- $25.70+1.27% (1D)
- Market cap
- 4.40B
- Price
- $8.65+1.95% (1D)
- Market cap
- 2.00B
- Price
- $18.50+2.29% (1D)
- Market cap
- 5.91B
- Price
- $83.95+0.11% (1D)
- Market cap
- 8.88B
- Price
- $74.50-0.81% (1D)
- Market cap
- 5.76B
- Price
- $102.19-5.41% (1D)
- Market cap
- 6.65B
- Price
- $22.57+3.39% (1D)
- Market cap
- 3.54B
- Price
- $294.63-7.06% (1D)
- Market cap
- 8.21B
- Price
- $47.15+0.37% (1D)
- Market cap
- 2.74B
- Price
- $33.28-4.86% (1D)
- Market cap
- 3.86B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
69/100 ⭐⭐⭐⭐
- Overall
- +0.5%
- NYSE
- +0.6%
- NASDAQ
- +0.5%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +1.6% | +2.6% | +3.7% | 19.2 | 98/100⭐⭐⭐⭐⭐ |
| Consumer Defensive | +1.4% | +3.5% | +2.4% | 30.2 | 78/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.5% | +1.1% | +1.4% | 24.0 | 69/100⭐⭐⭐⭐ |
| Communication Services | +0.6% | -1.4% | +2.2% | 22.0 | 67/100⭐⭐⭐⭐ |
| Basic Materials | +0.7% | +1.5% | +0.0% | 25.2 | 66/100⭐⭐⭐⭐ |
| Real Estate | +0.2% | +0.7% | -1.8% | 29.4 | 50/100⭐⭐⭐ |
| Energy | -0.5% | -2.2% | -2.6% | 19.4 | 41/100⭐⭐⭐ |
| Utilities | -0.8% | +0.2% | -4.2% | 26.9 | 36/100⭐⭐ |
| Consumer Cyclical | +0.2% | -1.8% | -6.1% | 42.6 | 18/100⭐ |
| Industrials | -0.4% | -0.6% | -10.8% | 29.8 | 18/100⭐ |
| Technology | -0.7% | -2.9% | -8.3% | 40.1 | 8/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-28.